FDA

[ad_1] The Food and Drug Administration approved the Pfizer-BioNTech Covid-19 vaccine “for emergency use” in children aged 5 to 11. The approval came after the FDA’s drug advisory panel recommended the approval on Tuesday. The Biden Administration says the doses of the shot will be at pediatricians’ offices, health centers, hospitals, pharmacies, and clinics, and that 15
[ad_1] The U.S. Food and Drug Administration (FDA) placed a clinical hold on Tryp Therapeutics’ Phase IIa trial for eating disorders, including binge eating disorder and hypothalamic obesity. No reason was cited for the hold, although Tryp expects additional information within 30 days. Tryp is developing psilocybin-based drugs. Psilocybin is a naturally occurring psychedelic prodrug
[ad_1]   The U.S. Food and Drug Administration (FDA) placed a clinical hold on Tryp Therapeutics’ Phase IIa trial for eating disorders, including binge eating disorder and hypothalamic obesity. No reason was cited for the hold, although Tryp expects additional information within 30 days. Tryp is developing psilocybin-based drugs. Psilocybin is a naturally occurring psychedelic
[ad_1] RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 9, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for Jardiance® (empagliflozin) as an investigational treatment for adults with heart failure with preserved ejection fraction (HFpEF), Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced today. The decision is based on results from